FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
The U.S. Food and Drug Administration today approved use of the seasonal influenza vaccine Fluarix to include children ages 3 years to 17 years. Previously, this vaccine, which contains inactivated (killed) influenza A and B viruses, had been approved for use in adults, ages 18 years and older.